Your browser doesn't support javascript.
loading
Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort.
Terrault, Norah A; Wahed, Abdus S; Feld, Jordan J; Cooper, Stewart L; Ghany, Mark G; Lisker-Melman, Mauricio; Perrillo, Robert; Sterling, Richard K; Khalili, Mandana; Chung, Raymond T; Rosenthal, Philip; Fontana, Robert J; Sarowar, Arif; Lau, Daryl T Y; Wang, Junyao; Lok, Anna S; Janssen, Harry L A.
Afiliação
  • Terrault NA; Gastrointestinal and Liver Diseases Division, Keck Medicine of University of Southern California, Los Angeles, California, USA.
  • Wahed AS; Department of Biostatistics and Epidemiology Data Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Feld JJ; Toronto Center for Liver Disease, University of Toronto, Toronto, Ontario, Canada.
  • Cooper SL; San Francisco Center for Liver Disease, California Pacific Medical & Research Institute, San Francisco, California, USA.
  • Ghany MG; Liver Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Lisker-Melman M; Washington University School of Medicine and John Cochran VA Medical Center, St. Louis, Missouri, USA.
  • Perrillo R; Baylor University Medical Center, Dallas, Texas, USA.
  • Sterling RK; Section of Hepatology, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Khalili M; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Chung RT; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Rosenthal P; Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Fontana RJ; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Sarowar A; Toronto Center for Liver Disease, University of Toronto, Toronto, Ontario, Canada.
  • Lau DTY; Liver Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
  • Wang J; Department of Biostatistics and Epidemiology Data Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Janssen HLA; Toronto Center for Liver Disease, University of Toronto, Toronto, Ontario, Canada.
Hepatology ; 75(3): 709-723, 2022 03.
Article em En | MEDLINE | ID: mdl-34743343

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Anticorpos Anti-Hepatite B / Antígenos de Superfície da Hepatite B Tipo de estudo: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Anticorpos Anti-Hepatite B / Antígenos de Superfície da Hepatite B Tipo de estudo: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article